Showing results (71-80 of 83) with videos related to
Sort By:
Pageof 9
Zhonghua Yi Xue Za Zhi|December 3, 2009
[Mechanism of cardioprotection induced by noninvasive limb ischemic preconditioning]Ning-Fu Wang, Jian Xu, Qiang Xia, et al.Science Bulletin|December 22, 2022
Long-term follow-up of haploidentical transplantation in relapsed/refractory severe aplastic anemia: a multicenter prospective studyLan-Ping Xu, Zheng-Li Xu, Shun-Qing Wang, et al.Acta Pharmacologica Sinica|January 13, 2025
Endothelial Gsα deficiency promotes ferroptosis and exacerbates atherosclerosis in apolipoprotein E-deficient mice via the inhibition of NRF2 signalingLi-Fan He, Lei Wang, Jing-Wei Li, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|June 1, 2013
Angiotensin-(1-7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cellsJian Min Yang, Mei Dong, Xiao Meng, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 3, 2012
Hepcidin destabilizes atherosclerotic plaque via overactivating macrophages after erythrophagocytosisJing Jing Li, Xiao Meng, Hai Peng Si, et al.Haematologica|May 26, 2022
Comparable long-term outcomes between upfront haploidentical and identical sibling donor transplant in aplastic anemia: a national registry-based studyZheng-Li Xu, Lan-Ping Xu, De-Pei Wu, et al.Science Bulletin|February 3, 2026
Who is the best allogeneic hematopoietic stem cell transplant donor for severe aplastic anemia? Data from the Chinese Bone Marrow Transplantation Registry Group (CBMTRG)Zheng-Li Xu, Lan-Ping Xu, Shun-Qing Wang, et al.Bone Marrow Transplantation|October 20, 2018
Preconditioning with fludarabine, busulfan and cytarabine versus standard BuCy2 for patients with acute myeloid leukemia: a prospective, randomized phase II studyWei-Ping Zhang, Zi-Wei Wang, Xiao-Xia Hu, et al.American Journal of Cancer Research|January 8, 2021
A novel prognostic scoring model for newly diagnosed FLT3-ITD-positive acute myeloid leukemiaYi Zhang, Bi-De Zhao, Cheng-Cheng Wang, et al.Acta Pharmacologica Sinica|March 30, 2021
Downregulation of c-Myc expression confers sensitivity to CHK1 inhibitors in hematologic malignanciesKai-Long Jiang, Le-Xian Tong, Tao Wang, et al.Pageof 9